As of June 21, 2025, Diego Pellicer Worldwide Inc (DPWW) reports a ROE (Return on Equity) of -40.03%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Diego Pellicer Worldwide Inc's ROE (Return on Equity)
Over recent years, Diego Pellicer Worldwide Inc's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2021-12-31 | -40.03% |
| 2020-12-31 | 28.56% |
| 2019-12-31 | 30.77% |
| 2018-12-31 | 83.55% |
| 2017-12-31 | 246.45% |
This slight downward trend highlights how Diego Pellicer Worldwide Inc manages its efficiency in generating profits from shareholders' equity over time.
Comparing Diego Pellicer Worldwide Inc's ROE (Return on Equity) to Peers
To better understand Diego Pellicer Worldwide Inc's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Diego Pellicer Worldwide Inc (DPWW) | -40.03% |
| Encounter Technologies Inc (ENTI) | 335.48% |
| Apotheca Biosciences Inc (CBDC) | 307.69% |
| DelphX Capital Markets Inc (DELX.V) | 184.45% |
| JPO Solutions Inc (MOPN) | 163.64% |
| Nascent Biotech Inc (NBIO) | 156.16% |
Compared to its competitors, Diego Pellicer Worldwide Inc's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.